Posts - CLL Support | HealthUnlocked
All posts for October 2023
Want to take advantage of all our features? Just log in!
or
Efficacy and safety of new‑generation BTKis (primarily acalabrutinib and zanubrutinib) in CLL/SLL: a systematic review and meta‑analysis
The meta-analysis of 20 studies on CLL/SLL patients treated with new-generation ...